Evidence map›Paper›PMID 22561485›Full record

ArticleNeurobiology of learning and memory2012

Differential effects of m1 and m2 receptor antagonists in perirhinal cortex on visual recognition memory in monkeys.

Wei Wu, Richard C Saunders, Mortimer Mishkin, Janita Turchi

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of learning and memory, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Antiamnesic and Neuroprotective Effects of an Aqueous Extract ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  3. Blockade of glutamatergic transmission in perirhinal cortex impairs object recognition memory in macaques.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  4. Memory loss in a nonnavigational spatial task after hippocampal inactivation in monkeys.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei WuLaboratory of Neuropsychology, NIMH, Bethesda, MD 20892, USA.
Richard C Saunders
Mortimer Mishkin
Janita Turchi

Funding

Pharmacology Of Stimulus Memory And Habit FormationZIAMH002039 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MISHKIN, MORTIMER · 2009 to 2017
$10.0M
Intramural NIH HHS ZIA MH002039
6 · The paper itself

Abstract

Microinfusions of the nonselective muscarinic antagonist scopolamine into perirhinal cortex impairs performance on visual recognition tasks, indicating that muscarinic receptors in this region play a pivotal role in recognition memory. To assess the mnemonic effects of selective blockade in perirhinal cortex of muscarinic receptor subtypes, we locally infused either the m1-selective antagonist pirenzepine or the m2-selective antagonist methoctramine in animals performing one-trial visual recognition, and compared these scores with those following infusions of equivalent volumes of saline. Compared to these control infusions, injections of pirenzepine, but not of methoctramine, significantly impaired recognition accuracy. Further, similar doses of scopolamine and pirenzepine yielded similar deficits, suggesting that the deficits obtained earlier with scopolamine were due mainly, if not exclusively, to blockade of m1 receptors. The present findings indicate that m1 and m2 receptors have functionally dissociable roles, and that the formation of new visual memories is critically dependent on the cholinergic activation of m1 receptors located on perirhinal cells.

Indexed as

AnimalsCerebral CortexDiaminesMacaca mulattaMaleMuscarinic AntagonistsPirenzepineReceptor, Muscarinic M1Receptor, Muscarinic M2Recognition, PsychologyScopolamineDiaminesmethoctramineMuscarinic AntagonistsPirenzepineReceptor, Muscarinic M1Receptor, Muscarinic M2Scopolamine

Identifiers

PMID22561485
PMCPMC3389587
OpenAlexW1986190676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.